Cargando…
The only way is up: priorities for implementing long-acting antiretrovirals for HIV prevention and treatment
PURPOSE OF REVIEW: Long-acting HIV treatment and prevention (LAHTP) can address some of the achievement gaps of daily oral therapy to bring us closer to achieving Joint United Nations Programme on HIV/AIDS Fast-track goals. Implementing these new technologies presents individual-level, population-le...
Autores principales: | Castor, Delivette, Meyers, Kathrine, Allen, Shannon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903331/ https://www.ncbi.nlm.nih.gov/pubmed/31688333 http://dx.doi.org/10.1097/COH.0000000000000601 |
Ejemplares similares
-
Formulation and pharmacology of long-acting cabotegravir
por: Trezza, Christine, et al.
Publicado: (2015) -
Long-acting antiviral agents for HIV treatment
por: Margolis, David A., et al.
Publicado: (2015) -
Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interval: an in silico modelling study
por: O’Neill, James R., et al.
Publicado: (2023) -
The place of long-acting injectable antipsychotics in the treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2023) -
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies
por: Bartoli, Francesco, et al.
Publicado: (2023)